Epitinib succinate

CAS No. 2252334-12-4

Epitinib succinate( —— )

Catalog No. M28061 CAS No. 2252334-12-4

Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 93 In Stock
5MG 164 In Stock
10MG 272 In Stock
25MG 449 In Stock
50MG 603 In Stock
100MG 826 In Stock
200MG Get Quote In Stock
500MG 1655 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epitinib succinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.
  • Description
    Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.
  • In Vitro
    Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    lysosomal acid lipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2252334-12-4
  • Formula Weight
    548.59
  • Molecular Formula
    C28H32N6O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (22.79 mM)
  • SMILES
    N/A
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rosenbaum et al (2009) Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors. Biochim.Biophys.Acta. 1791 1155
molnova catalog
related products
  • Bemnifosbuvir hemisu...

    Bemnifosbuvir hemisulfate is a potent inhibitor of HCV virus replication.

  • Lucidenic acid O

    Lucidenic acid O is a terpene compound, is a DNA polymerases inhibitor. Lucidenic lactone inhibits calf DNA polymerase-α, rat DNA polymerase-β, and HIV-1 reverse transcriptase with IC50 values of 42 μM, 99 μM, and 69 μM, respectively.

  • NP-G2-044

    NP-G2-044 is an orally active fascin inhibitor, with an IC50 of ~2 μM. It blocks tumor metastasis and increases antitumor immune response.